Publications by authors named "Steve Weitman"

Claim this Profile
A
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.
Hiroyuki Takabe, Zachary N Warnken, Yajie Zhang, Daniel A Davis, Hugh D C Smyth, Steve Weitman

Pharmaceutics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
Zachary N Warnken, Hugh D C Smyth, Daniel A Davis, Steve Weitman, John G Kuhn

Mol Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of elderly patients (≥70 years old) enrolled in Phase I clinical trials at University of Texas Health Science Center at San Antonio-Cancer Therapy Research Center from 2009 to 2011.
Julie Rowe, Sukeshi Patel, Marcela Mazo-Canola, Alberto Parra, Martin Goros, Steve Weitman

J Geriatr Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of a Minority Recruitment Plan for Cancer Clinical Trials.
Monica Trevino, Susan Padalecki, Anand Karnad, Alberto Parra, Steve Weitman

J Community Med Health Educ· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Peter L Bonate, Casey C Cunningham, Paul Gaynon, Sima Jeha, Richard Kadota, Steve Weitman

Cancer Chemother Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
Peter L Bonate, Larry Arthaud, William R Cantrell, Katherine Stephenson, John A Secrist, Steve Weitman

Nat Rev Drug Discov· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.
Alain C Mita, Lisa A Hammond, Peter L Bonate, Geoffrey Weiss, Heather McCreery, Steve Weitman

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.
Scot Ebbinghaus, Eric Rubin, Evan Hersh, Lee D Cranmer, Peter L Bonate, Steve Weitman

Clin Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors.
Casey Cunningham, Leonard J Appleman, Miora Kirvan-Visovatti, David P Ryan, Eileen Regan, Steve Weitman

Clin Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
Seth J Corey, Marily Elopre, Steve Weitman, Michael E Rytting, Lisa J Robinson

J Pediatr Hematol Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Peter L Bonate, Adam Craig, Paul Gaynon, Varsha Gandhi, Sima Jeha, Steve Weitman

J Clin Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of a kinesin inhibitor.
Roman Sakowicz, Jeffrey T Finer, Christophe Beraud, Anne Crompton, Evan Lewis, Steve Weitman

Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
Victor M Aquino, Steve D Weitman, Naomi J Winick, Susan Blaney, Wayne L Furman

J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study.
Robert J Hayashi, Susan Blaney, Jim Sullivan, Steve Weitman, Teresa Vietti

J Pediatr Hematol Oncol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbendazim: disposition, cellular permeability, metabolite identification, and pharmacokinetic comparison with its nanoparticle.
Lee Jia, Hong Wong, Yao Wang, Mark Garza, Steve D Weitman

J Pharm Sci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry.
Lee Jia, Hong Wong, Cesario Cerna, Steve D Weitman

Pharm Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Cory L Grand, Haiyong Han, Rubén M Muñoz, Steve Weitman, Daniel D Von Hoff

Mol Cancer Ther· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice.
Lee Jia, Mark Garza, Hong Wong, Dody Reimer, Thomas Redelmeier, Steve D Weitman

J Pharm Biomed Anal· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of DNA ligase I level by gemcitabine in human cancer cells.
Daekyu Sun, Rheanna Urrabaz, Susan Kelly, Myhanh Nguyen, Steve Weitman

Clin Cancer Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis